Lexicon Q1 ’17 Earnings Update
Lexicon hosted its Q1 earnings call and provided updates to their T1DM and T2DM diabetes development programs for sotagliflozin and LX2761.
Lexicon hosted its Q1 earnings call and provided updates to their T1DM and T2DM diabetes development programs for sotagliflozin and LX2761.
Lexicon hosted its Q4 and full-year 2016 earnings call and provided an update to its diabetes pipeline.
Lexicon recently presented at the Leerink Global Healthcare Conference and provided updates to its diabetes development programs.